In our series, one combined PCC-NOS and SRC carcinoma (with an SRC component accounting for 30% of the neoplastic growth) arising in a 39-year-old woman affected by Crohn disease showed an IDH1 pathogenic mutation. This evidence concerns the gene SRC and adrenal gland pheochromocytoma.